<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04717063</url>
  </required_header>
  <id_info>
    <org_study_id>CRO-2020-08-BAC-HP-CA-BGS2</org_study_id>
    <nct_id>NCT04717063</nct_id>
  </id_info>
  <brief_title>Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria Saliva and Bioaerosol Contamination Phase 2</brief_title>
  <official_title>Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria in Saliva and Bioaerosol Contamination Phase 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Colgate Palmolive</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Colgate Palmolive</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the antibacterial efficacy of a commercial mouthwash containing 1.5% hydrogen&#xD;
      peroxide in reducing the levels of bacteria in bioaerosols generated by dental prophylaxis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Following a washout period, subjects will return to the clinical site. A baseline microbial&#xD;
      sample will be collected from the operatory's atmosphere for 30 min. prior to the study&#xD;
      subject appointment by placing blood agar plates on a support board attached to the bracket&#xD;
      chair tray. Upon completion of a half-mouth (e.g. right side) dental prophylaxis, each study&#xD;
      subject will be instructed to rinse for one minute with 10 ml of one of the two mouthwash&#xD;
      solutions (1.5% hydrogen peroxide or 0.0% hydrogen peroxide) and to expectorate all remaining&#xD;
      liquid. Next, the dental prophylaxis will be completed on the other side of the mouth.&#xD;
      Bioaerosol samples will be collected prior to and following rinsing on blood agar plates&#xD;
      placed on a support board at a 50-degree angle to the participant's chest, on the&#xD;
      participant's chest, and on the examiner's forehead. Plates will be closed and labeled. The&#xD;
      plates will be transferred to the microbiology laboratory for analysis. All subjects will be&#xD;
      followed for adverse events throughout the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 16, 2020</start_date>
  <completion_date type="Actual">January 7, 2021</completion_date>
  <primary_completion_date type="Actual">December 30, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Each subject will be randomized to receive one of the two possible study products</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
    <masking_description>Triple (Participant, Investigator, Outcome Assessor)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>evaluate the antibacterial efficacy of mouthwash in reducing the levels of bacteria in bioaerosols generated by dental prophylaxis</measure>
    <time_frame>30 min</time_frame>
    <description>baseline microbial sample will be collected from the operatory's atmosphere for 30 min. prior to the study subject appointment by placing blood agar plates on a support board attached to the bracket chair tray. Upon completion of a half-mouth (e.g. right side) dental prophylaxis, each study subject will be instructed to rinse for one minute with 10 ml of one of the two mouthwash solutions (1.5% hydrogen peroxide or 0.0% hydrogen peroxide) and to expectorate all remaining liquid. Next, the dental prophylaxis will be completed on the other side of the mouth. Bioaerosol samples will be collected prior to and following rinsing on blood agar plates placed on a support board at a 50-degree angle to the participant's chest, on the participant's chest, and on the examiner's forehead. Plates will be closed and labeled. The plates will be transferred to the microbiology laboratory for analysis</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Peroxyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug: Peroxyl Mouthwash Mouthwash&#xD;
Other Names:&#xD;
• 1.5% HP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo mouthwash</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Drug: Placebo Mouthwash Mouthwash&#xD;
Other Names:&#xD;
• 0.0% HP Mouthwash</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Peroxyl Oral Product</intervention_name>
    <description>mouth wash</description>
    <arm_group_label>Peroxyl</arm_group_label>
    <other_name>Peroxyl Mouth wash</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo mouth wash</description>
    <arm_group_label>placebo mouthwash</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Potential subjects must meet ALL of the following criteria:&#xD;
&#xD;
               -  Subjects, ages 18-70, inclusive.&#xD;
&#xD;
               -  Availability for the duration of this clinical research study.&#xD;
&#xD;
               -  Good general health.&#xD;
&#xD;
               -  At least 20 natural teeth.&#xD;
&#xD;
               -  Gingivitis Index 1.0 (Löe-Silness).&#xD;
&#xD;
               -  Signed Informed Consent Form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Potential subjects must NOT HAVE ANY of the following conditions:&#xD;
&#xD;
               -  Symptoms consistent with COVID-19 or have tested positive.&#xD;
&#xD;
               -  Presence of orthodontic bands.&#xD;
&#xD;
               -  Tumor(s) of the soft or hard tissues of the oral cavity.&#xD;
&#xD;
               -  Advanced periodontal disease (purulent exudate, tooth mobility, and/or extensive&#xD;
                  loss of periodontal attachment or alveolar bone) or peri-implantitis.&#xD;
&#xD;
               -  Five or more carious lesions requiring immediate restorative treatment.&#xD;
&#xD;
               -  Use of antibiotic one-month prior to entry into the study.&#xD;
&#xD;
               -  Participation in any other clinical study or test panel within the one month&#xD;
                  prior to entry into the study.&#xD;
&#xD;
               -  Dental prophylaxis during the past two weeks prior to baseline examinations.&#xD;
&#xD;
               -  History of allergies to oral care/personal care consumer products or their&#xD;
                  ingredients.&#xD;
&#xD;
               -  On any prescription medicines that might interfere with the study outcome.&#xD;
&#xD;
               -  An existing medical condition that prohibits not eating or drinking for periods&#xD;
                  up to 4 hours.&#xD;
&#xD;
               -  History of alcohol or drug abuse.&#xD;
&#xD;
               -  Self-reported pregnant or lactating subjects.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yiming Li, DDS MSD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Loma Linda University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Loma Linda University</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92350</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 20, 2021</study_first_posted>
  <last_update_submitted>January 19, 2021</last_update_submitted>
  <last_update_submitted_qc>January 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mouthwash</keyword>
  <keyword>Saliva</keyword>
  <keyword>Bioaerosol</keyword>
  <keyword>Bacteria</keyword>
  <keyword>Gingivitis</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrogen Peroxide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

